MetLife Investment Management, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$100,142
-16.3%
92,7240.0%0.00%0.0%
Q2 2023$119,614
-2.3%
92,7240.0%0.00%0.0%
Q1 2023$122,396
+25.9%
92,724
+43.1%
0.00%0.0%
Q4 2022$97,208
-13.6%
64,805
-32.0%
0.00%0.0%
Q3 2022$112,530
+1190.5%
95,364
+1135.8%
0.00%
Q2 2022$8,720
-96.6%
7,717
-91.0%
0.00%
-100.0%
Q1 2022$256,273
+226.9%
85,710
+189.7%
0.00%
+100.0%
Q4 2021$78,390
-64.9%
29,581
-52.0%
0.00%
-50.0%
Q3 2021$223,485
+23.5%
61,566
+47.6%
0.00%0.0%
Q2 2021$180,995
-23.7%
41,704
-39.8%
0.00%0.0%
Q1 2021$237,095
+41.8%
69,326
+45.1%
0.00%0.0%
Q4 2020$167,234
+48.0%
47,781
+1.5%
0.00%
+100.0%
Q3 2020$113,009
-23.8%
47,087
-41.9%
0.00%
-50.0%
Q2 2020$148,210
+139.0%
80,989
+103.8%
0.00%
+100.0%
Q1 2020$62,005
-65.2%
39,747
-52.3%
0.00%
-50.0%
Q4 2019$178,345
+588.0%
83,339
+501.2%
0.00%
Q3 2019$25,924
-90.7%
13,863
-87.1%
0.00%
-100.0%
Q2 2019$279,821
+59.8%
107,211
+57.3%
0.00%
+50.0%
Q1 2019$175,140
+11.7%
68,1480.0%0.00%0.0%
Q4 2018$156,740
-28.3%
68,1480.0%0.00%0.0%
Q3 2018$218,755
-23.8%
68,148
-32.8%
0.00%
-33.3%
Q2 2018$287,000
+22.1%
101,362
+53.0%
0.00%0.0%
Q1 2018$235,000
-8.6%
66,2700.0%0.00%0.0%
Q4 2017$257,00066,2700.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders